PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A 3-month randomized double-blind trial showed significant upgrading in 4 of 5 IIEF-5 descriptive evaluations, with 82.4% of patients exhibiting noticeable improvement [PMID:12937809]. However, another open-label study found positive responses that could not be repeated in a subsequent double-blind phase [PMID:19624593].
In aged male rats, ethanolic extract (50-200 mg/kg) ameliorated scopolamine-induced cognitive impairment in Y-maze, novel object recognition, and passive avoidance tests [PMID:34671404].
Administration of Butea superba (300 mg/kg) in mice exposed to chronic mild stress showed antidepressant-like activity [PMID:25152298].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 23086155 (2013) — Discrimination of the Thai rejuvenating herbs Pueraria candollei (White Kwao Khruea), Butea superba (Red Kwao Khruea), and Mucuna collettii (Black Kwao Khruea) using PCR-RFLP. · Journal of natural medicines
- 2.PMID: 31377923 (2020) — Evaluation of white Kwao Krua (Pueraria candollei Grah. ex Benth.) products sold in Thailand by molecular, chemical, and microscopic analyses. · Journal of natural medicines
- 3.PMID: 15234761 (2004) — The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. · Journal of ethnopharmacology
- 4.PMID: 33020994 (2021) — Immunochromatographic assay for the detection of kwakhurin and its application for the identification of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham. · Phytochemical analysis : PCA
- 5.PMID: 24660477